Editors Choice

3/recent/post-list

2 stocks for swing trading this week

2 stocks for swing trading this week

Uncover the best 2 stocks for swing trading this week. Enhance your trading strategy with our expert analysis and stay ahead in the market

Endurance Technologies Limited (ENDURANCE)

  1. Current Price: 1,898.55
  2. Price Target: - Target Price: 1,950.00 This target is based on recent resistance levels and potential upward momentum.
  3. Potential Gain: - Potential Gain %: Approximately 2.7% from the current price.
  4. Stop-Loss: - Stop-Loss Price: 1,850.00
    - This stop-loss is set to limit potential losses and is below recent support levels.
  5. Estimated Time to Completion: - Time Frame: Approximately 1-2 weeks.
Summary:- Buy ENDURANCE at 1,898.55
  • Target Price: 1,950.00
  • Potential Gain: 2.7%
  • Stop-Loss: 1,850.00
  • Estimated Time to Completion :1-2 weeks
Endurance Technologies Limited
Endurance Technologies Limited

Glenmark Pharmaceuticals Limited (GLENMARK)

  1. Current Price: 1,420.95
  2. Price Target: - Target Price: 1,480.00 This target is based on recent resistance levels and potential upward momentum.
  3. Potential Gain: - Potential Gain %: Approximately 4.2% from the current price.
  4. Stop-Loss: - Stop-Loss Price: 1,390.00 This stop-loss is set to limit potential losses and is below recent support levels.
  5. Estimated Time to Completion: - Time Frame: Approximately 1-2 weeks.

Summary:- Buy GLENMARK at 1,420.95

  •  Target Price: 1,480.00
  • Potential Gain: 4.2%
  • Stop-Loss: 1,390.00
  • Stop-Loss: 1,390.00 : 1-2 weeks
Glenmark Pharmaceuticals Limited (GLENMARK) is a prominent player in the pharmaceutical industry, and here’s a deeper analysis for swing trading:

  1. Current Market PositionCurrent Price: 1,420.95
    52-Week Range: 883.5
    -1,830.05
    Recent Performance: The stock is currently trading 58.03% above its 52-week low, indicating a strong recovery trend.
  2. Technical IndicatorsLatest EMA (Exponential Moving Average): 1,380.18
    Latest MACD (Moving Average Convergence Divergence): -10.23, suggesting a potential bullish crossover.
    Latest RSI (Relative Strength Index): 54.64, indicating that the stock is neither overbought nor oversold, which is favorable for swing trading.
  3. Recent Price MovementsIntraday Volatility: The stock has shown some fluctuations, with a recent 5-minute price change of 0.1125% and a 1-hour change of 0.6628%. This indicates active trading, which is beneficial for swing traders looking for short-term gains.
  4. FundamentalsMarket Capitalization: 395.19B
    Trailing P/E Ratio: 86.30, which may suggest that the stock is currently valued higher relative to its earnings, but this can be justified if growth prospects are strong.
    Profit Margin: -1.3%, indicating some challenges in profitability, but the company may be investing heavily in growth.
  5. Swing Trading StrategyEntry Point: Consider entering at the current price of 1,420.95.
    Target Price: Aim for 1,480.00, which aligns with recent resistance levels.
    Stop-Loss: Set at 1,390.00 to manage risk effectively.
  6. Market SentimentThe stock has a quarterly revenue growth of 35.1%, indicating strong sales performance, which can attract more investors and drive the price higher.
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited

Conclusion: Glenmark Pharmaceuticals presents a favorable opportunity for swing trading with a clear target and manageable risk. The combination of technical indicators and recent performance suggests potential for upward movement in the coming weeks. Disclaimer: Remember, this analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research or consult a financial advisor before making any investment decisions.